1、Multi-therapies Based on PARP Inhibition: Potential Therapeutic Approaches for Cancer Treatment. https://doi.org/10.1021/acs.jmedchem.2c01352 2、PARP Inhibitors as therapeutics: Beyond modulation of PARylation. Cancers 2020, 12 (2), 394. 3、New PARP targets ...
PARP inhibitors and cancer therapy-early results and potential applications [J]. Br J Radiol, 2008, 81(l): S2-S5. [2] Drew Y, Plummer R. PARP inhibitors in cancer therapy: two modes of attack on the cancer cell widening the clinical applications [J]. Drug Resist Updat, 2009, 12(6...
5.Tew WP, Lacchetti C, Kohn EC PARP Inhibitors in the Management of Ovarian Cancer Guideline Expert Panel. Poly(ADP-ribose) polymerase inhibitors in the management of ovarian cancer: ASCO guideline rapid recommendation upd...
[6].Peraltaleal A, Rodriguezvargas J M, Aguilarquesada R, et al. PARP inhibitors: New partners in the therapy of cancer and inflammatory diseases[J]. Free Radical Biology and Medicine, 2009, 47(1): 13-26.DOI:10.1016/j.freeradbiomed.2009.04.008 [7].Langelier M, Riccio A A, Pascal J...
[13] Nidal E. Muvarak et al. Enhancing the Cytotoxic Effects of PARP Inhibitors with DNA Demethylating Agents – A Potential Therapy for Cancer. Cancer Cell(2016). 30(4): 637-650. ▼往期精彩回顾▼ Angew:构建无环四取代氟立体中心的新途径-α氟酮的曼尼希不对称加成 ...
Curtin NJ (2005) PARP inhibitors for cancer therapy. Expert Rev Mol Med. 15: 1-20.Curtin NJ (2005) PARP inhibitors for cancer therapy. Expert Rev Mol Med 15:1-20Lin KY and Kraus WL (2017) PARP inhibitors for cancer therapy. Cell 169:183....
[4]Nidal E. Muvarak et al. Enhancing the Cytotoxic Effects of PARP Inhibitors with DNA Demethylating Agents – A Potential Therapy for Cancer. Cancer Cell(2016). 参考资料: 1#PARP inhibitor pick-me-up(来源:Nature Reviews Drug Discovery) ...
[6].Peraltaleal A, Rodriguezvargas J M, Aguilarquesada R, et al. PARP inhibitors: New partners in the therapy of cancer and inflammatory diseases[J]. Free Radical Biology and Medicine, 2009, 47(1): 13-26.DOI:10.1016/j.freeradbiomed.2009.04.008 ...
[2] Dias MP, Moser SC, Ganesan S, et al. Understanding and overcoming resistance to PARP inhibitors in cancer therapy. Nat Rev Clin Oncol. 2021;18(12):773-791. [3] Curtin NJ, Szabo C. Poly(ADP-ribose) polymerase inhibition: past, present and future. Nat Rev Drug Discov. 2020;19(...
[6].Peraltaleal A, Rodriguezvargas J M, Aguilarquesada R, et al. PARP inhibitors: New partners in the therapy of cancer and inflammatory diseases[J]. Free Radical Biology and Medicine, 2009, 47(1): 13-26.DOI:10.1016/j.freeradbiomed.2009.04.008 ...